Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SPI 47

Next Previous
X
Search
Drug Profile

SPI 47

Alternative Names: Prednisolone/SPI-62 - Sparrow Pharmaceuticals; SPI-47; SPI-62/prednisolone - Sparrow Pharmaceuticals

Latest Information Update: 14 Oct 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sparrow Pharmaceuticals
  • Class Anti-inflammatories; Antiallergics; Antineoplastics; Antirheumatics; Corticosteroids; Glucocorticoids; Pregnadienetriols; Small molecules
  • Mechanism of Action 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; Glucocorticoid receptor agonists; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Polymyalgia rheumatica

Most Recent Events

  • 06 Oct 2022 Phase-II clinical trials in Polymyalgia rheumatica in USA (PO)(Sparrow Pharmaceuticals pipeline, October 2022).
  • 01 Jun 2022 Sparrow Pharmaceuticals plans a phase II trial for Polymyalgia rheumatica, in June 2022
  • 01 Jun 2022 Preclinical trials in Polymyalgia rheumatica in USA (PO), prior to June 2022

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top